海王生物：拟转让河南东森医药有限公司股权

Group 1 - The core point of the article is that Haiwang Biological announced a share transfer agreement where its subsidiary, Henan Haiwang Group, will sell 100% of its stake in Henan Dongsen for approximately 248 million yuan [1] - After the completion of the share transfer, Henan Huicheng will hold 100% of Henan Dongsen's shares, and Henan Haiwang Group will no longer have any equity interest in Henan Dongsen [1] - Following this transaction, Henan Dongsen will no longer be included in the consolidated financial statements of the company [1]